Challenge
Over 19 million women in the US are in need of contraception yet lack reasonable access, creating barriers to control their own sexual health. In 2023, Perrigo secured FDA approval for Opill, the first over-the-counter birth control pill available in the US. To make Opill truly accessible, we needed to drive awareness of its safety and efficacy, and build a digital hub complete with a user-friendly ecommerce platform for nationwide access.